← Back to Search

Quality Improvement and Implementation Science for Mental and Physical Health in Women Veterans (EMPOWER Trial)

N/A
Recruiting
Led By Alison B Hamilton, PhD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing two strategies to help support and sustain evidence-based practices for women Veterans in up to 20 VA facilities.

Who is the study for?
This trial is for VA facilities that serve women veterans. It's not for individual patients. Facilities must have leadership support to participate and are prepared to implement evidence-based practices aimed at improving health outcomes in areas like diabetes, obesity, depression, and cardiovascular disease.
What is being tested?
The EMPOWER QUERI 2.0 Program is testing two strategies (EBQI and REP) across up to 20 VA facilities to see which better supports the implementation of healthcare practices designed for women veterans' mental and physical health.
What are the potential side effects?
Since this study focuses on facility-level interventions rather than direct patient treatments, it does not involve side effects in the traditional sense of medical interventions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Access to virtual care for preventive services
Engagement in virtual care for preventive services
Secondary study objectives
Participation and engagement: DPP
Participation and engagement: ROSE
Participation and engagement: TLC

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: EBQIExperimental Treatment1 Intervention
Evidence-Based Quality Improvement (EBQI) is a higher-intensity implementation strategy that entails external facilitation and formal training in quality improvement.
Group II: REPActive Control1 Intervention
Replicating Effective Practices (REP) is a lower-intensity implementation strategy with explicit process framework for local tailoring

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor
1,663 Previous Clinical Trials
3,765,756 Total Patients Enrolled
3 Trials studying Telemedicine
939 Patients Enrolled for Telemedicine
Alison B Hamilton, PhD MPHPrincipal InvestigatorVA Greater Los Angeles Healthcare System, West Los Angeles, CA
2 Previous Clinical Trials
174 Total Patients Enrolled

Media Library

DPP Clinical Trial Eligibility Overview. Trial Name: NCT05050266 — N/A
Telemedicine Research Study Groups: REP, EBQI
Telemedicine Clinical Trial 2023: DPP Highlights & Side Effects. Trial Name: NCT05050266 — N/A
DPP 2023 Treatment Timeline for Medical Study. Trial Name: NCT05050266 — N/A
~4 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top